Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Startups & Unicorns companies in Hyperlipidemia
by Highest Patent Value in the United States in 2022

The Hyperlipidemia top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Hyperlipidemia Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 2.76 M
2
Medicine,Medical equipment,Health care,
...[+2]
Avg patent value: 450,000
3
Arkay Therapeutics LLC
Diabetes Therapy,Health care
Avg patent value: 88,000
4
Epirium
Mitochondrial biogenesis,Biology,Health care,
...[+2]
Avg patent value: 28,000
5
Steatohepatitis,Medicine,Health care,
...[+2]
Avg patent value: 0
Page generation time: May 21 2025